tirzepatide deaths linked to lower risk for death, adverse CV and kidney outcomes vs. GLP-1s 📌 Most viewed this week

REMEVi delivers GLP-1 weight-loss care through licensed US providers with one all-inclusive price covering clinical review, medication, shipping, and support

Mimura K, Teh JL, Okayama H, Shiraishi K, Kua L-F, Koh V, Smoot DT, Ashktorab H, Oike T, Suzuki Y, et al

Managing type 2 diabetes and obesity has seen significant advancements with the introduction of GLP-1 receptor agonists like semaglutide and the newer dual agonist tirzepatide

GLP-1 medications affect appetite regulation and gastric emptying, processes that can interact with hormonal fluctuations during your menstrual cycle

As BPC157 is a short peptide lacking commercially available antibodies, we synthesized biotin-labeled BPC157 and performed coimmunoprecipitation (co-IP) assays using biotin-specific antibodies